ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
Clinical trial NCT03287271 · TERMINATED
Trial details
- NCT number
- NCT03287271
- Sponsor
- Michael McHale
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-06
- Primary completion
- 2023-07-30
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.